Atlas Trials

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) (Protocol Number: 2449-US-002)

Clinical trial NCT00779480 · TERMINATED

Trial details

NCT number
NCT00779480
Sponsor
Kyowa Kirin Co., Ltd.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myelogenous Leukemia (AML)
Start date
2009-01-01
Primary completion
2010-04-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.